Home > Food & Beverages > Nutraceuticals > Diamine Oxidase Enzyme Market

Diamine Oxidase Enzyme Market Trends

Report ID: GMI7077
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Diamine Oxidase Enzyme Market Trends

Companies are investing in the development of more effective supplements and innovative formulations, addressing the needs of individuals with histamine intolerance. On the flip side, the market has encountered regulatory challenges, particularly concerning dietary supplement regulations, which can vary across regions, leading to uncertainties for businesses in this sector.

Authors: Kiran Pulidindi, Manish Mohanan

Frequently Asked Questions (FAQ) :

The market size of diamine oxidase enzyme reached USD 21.86 million in 2022 and is set to cross USD 38.13 million by 2032, due to the rising gastrointestinal discomfort and skin issues.

The liquid form segment crossed USD 10.5 million in revenue in 2022, owing to their ability to be more easily absorbed by the body compared to solid dosage forms, such as capsules or tablets.

North America market size was valued at USD 8.8 million in 2022, driven by the increased awareness of histamine intolerance and related conditions.

Some of the leading diamine oxidase enzyme providers are DR Healthcare, Seeking Health, LLC, Eat All (Stada Group), Pure Encapsulations, LLC, Enzymedica, Inc., and Swanson.